This Article Figures Only Full Text Full Text (PDF) Online Appendix View Related Story on Cardiosmart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Groenveld, H. F. Articles by van der Meer, P. PubMed Articles by Groenveld, H. F. Articles by van der Meer, P. Related Collections Related Article

CLINICAL RESEARCH: HEART FAILURE

Anemia and Mortality in Heart Failure Patients

A Systematic Review and Meta-Analysis

Hessel F. Groenveld, MD^_*, James L. Januzzi, MD, FACC, Kevin Damman, MD^_*, Jan van Wijngaarden, MD, PhD, Hans L. Hillege, MD, PhD^_*, Dirk J. van Veldhuisen, MD, PhD, FACC^_* and Peter van der Meer, MD, PhD^,_*

^_* Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands
Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Department of Cardiology, Deventer Hospital, Deventer, the Netherlands

Manuscript received February 19, 2008; revised manuscript received April 23, 2008, accepted April 28, 2008.

^_* Reprint requests and correspondence: Dr. Peter van der Meer, Cardiovascular Research Center, Massachusetts General Hospital, Charles River Plaza, 185 Cambridge Street, Boston, Massachusetts 02114 (Email: pvandermeer{at}partners.org).

Objectives: The aim of this study was to assess the effect of anemia on mortality in chronic heart failure (CHF).

Background: Anemia is frequently observed in patients with CHF, and evidence suggests that anemia might be associated with an increased mortality.

Methods: A systematic literature search in MEDLINE (through November 2007) for English language articles was performed. In addition, a manual search was performed. We included cohort studies and retrospective secondary analyses of randomized controlled trials whose primary objective was to analyze the association between anemia and mortality in CHF. Of a total of 1,327 initial studies, we included 34 studies, comprising 153,180 patients. Information on study design, patient characteristics, outcome, and potential confounders were extracted.

Results: Anemia was defined by criteria used in the original articles. Of the 153,180 CHF patients, 37.2% were anemic. After a minimal follow-up of 6 months, 46.8% of anemic patients died compared with 29.5% of nonanemic patients. Crude mortality risk of anemia was odds ratio 1.96 (95% confidence interval: 1.74 to 2.21, p < 0.001). Lower baseline hemoglobin values were associated with increased crude mortality rates (r = –0.396, p = 0.025). Adjusted hazard ratios showed an increased adjusted risk for anemia (hazard ratio 1.46 [95% confidence interval: 1.26 to 1.69, p < 0.001]). Subgroup analysis showed no significant difference between mortality risk of anemia in diastolic or systolic CHF.

Conclusions: Anemia is associated with an increased risk of mortality in both systolic and diastolic CHF. Anemia should, therefore, be considered as a useful prognosticator, and therapeutic strategies aimed to increase hemoglobin levels in CHF should be investigated.

Key Words: heart failure • anemia • prognosis

Abbreviations and Acronyms   CHF = chronic heart failure   CI = confidence interval   EPO = erythropoietin   ESP = erythropoiesis-stimulating protein   Hb = hemoglobin   HR = hazard ratio   Ht = hematocrit   OR = odds ratio   WHO = World Health Organization

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31-A32. [Full Text] [PDF]

This article has been cited by other articles:

				P. van der Meer, J. L. Januzzi, and D. J. van Veldhuisen Erythropoietin, haemoglobin, heart failure, and mortality: reply Eur. Heart J., November 1, 2008; 29(21): 2695 - 2696. [Full Text] [PDF]